Skip to main content

Advertisement

Log in

Wnt/beta-Catenin Signaling in Glioma

  • INVITED REVIEW
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

Extensive data have shown that Wnt/beta-catenin signaling is associated with various disease pathologies, including an important role in tumorigenesis. Here, we review the regulation of Wnt/beta-catenin signaling in glioma, with particular focus on the expression signatures of the main components in Wnt/beta-catenin signaling, the role of key factors in Wnt/beta-catenin signaling, and crosstalk with other signaling pathways. Finally, we discuss the involvement of microRNAs in Wnt/beta-catenin signaling in glioma. This review reveals new insights into the role of Wnt/beta-catenin signaling in gliomagenesis, and highlights new therapeutic approaches for glioma, based on the modulation of the Wnt/beta-catenin pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

TCF/LEF:

T cell factor/lymphoid enhancer factor

LRP:

LDL-receptor-related protein

Dsh:

Disheveled

APC:

Adenomatous polyposis coli

GSK:

Glycogen synthase kinase

CtBP:

C-terminal-binding protein

CK1:

Casein kinase 1

CBP:

Cyclic AMP response element-binding protein

p300:

E1A binding protein p300

DKK:

Dickkopf

SFRP:

Secreted frizzled-related proteins

UCSC:

University of California Santa Cruz

WIF:

Wnt inhibitory factor

HSPG:

Heparin-sulfated forms of proteoglycans

EGFR:

Epidermal growth factor receptor

PKM2:

Pyruvate kinase M2

STAT3:

Signal transducer and activator of transcription 3

UTR:

Untranslated region

PI3K:

Phosphatidylinositol 3-kinase

VHL:

Von Hippel-Lindau

NSAIDs:

Nonsteroidal anti-inflammatory drugs

References

  • Aberle H, Bauer A, Stappert J, Kispert A, Kemler R (1997) beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16:3797–804

    Article  PubMed  CAS  Google Scholar 

  • Ambros V (2001) microRNAs: tiny regulators with great potential. Cell 107:823–6

    Article  PubMed  CAS  Google Scholar 

  • Anand M, Lai R, Gelebart P (2011) beta-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Haematologica 96:253–61

    Article  PubMed  CAS  Google Scholar 

  • Anton R, Chatterjee SS, Simundza J, Cowin P, Dasgupta R (2011) A systematic screen for micro-RNAs regulating the canonical Wnt pathway. PLoS One 6:e26257

    Article  PubMed  CAS  Google Scholar 

  • Armanious H, Gelebart P, Mackey J, Ma Y, Lai R (2010) STAT3 upregulates the protein expression and transcriptional activity of beta-catenin in breast cancer. Int J Clin Exp Pathol 3:654–64

    PubMed  CAS  Google Scholar 

  • Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284:770–6

    Article  PubMed  CAS  Google Scholar 

  • Ayyanan A, Civenni G, Ciarloni L, Morel C, Mueller N, Lefort K, Mandinova A, Raffoul W, Fiche M, Dotto GP, Brisken C (2006) Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A 103:3799–804

    Article  PubMed  CAS  Google Scholar 

  • Azim K, Butt AM (2011) GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. GLIA 59:540–53

    Article  PubMed  Google Scholar 

  • Baker NE (1988) Transcription of the segment-polarity gene wingless in the imaginal discs of Drosophila, and the phenotype of a pupal-lethal wg mutation. Development 102:489–97

    PubMed  CAS  Google Scholar 

  • Bos CL, Kodach LL, van den Brink GR, Diks SH, van Santen MM, Richel DJ, Peppelenbosch MP, Hardwick JC (2006) Effect of aspirin on the Wnt/beta-catenin pathway is mediated via protein phosphatase 2A. Oncogene 25:6447–56

    Article  PubMed  CAS  Google Scholar 

  • Brantjes H, Barker N, van Es J, Clevers H (2002) TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling. Biol Chem 383:255–61

    Article  PubMed  CAS  Google Scholar 

  • Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr (1999) Stat3 as an oncogene. Cell 98:295–303

    Article  PubMed  CAS  Google Scholar 

  • Caricasole A, Ferraro T, Iacovelli L, Barletta E, Caruso A, Melchiorri D, Terstappen GC, Nicoletti F (2003) Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins. J Biol Chem 278:37024–31

    Article  PubMed  CAS  Google Scholar 

  • Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318–25

    Article  PubMed  CAS  Google Scholar 

  • Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, Roth MG, Amatruda JF, Chen C, Lum L (2009a) Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5:100–7

    Article  PubMed  CAS  Google Scholar 

  • Chen HC, Chen GH, Chen YH, Liao WL, Liu CY, Chang KP, Chang YS, Chen SJ (2009b) MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer 100:1002–11

    Article  PubMed  CAS  Google Scholar 

  • Chen L, Huang K, Han L, Shi Z, Zhang K, Pu P, Jiang C, Kang C (2011a) Beta-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma. Int J Oncol 39:883–90

    PubMed  CAS  Google Scholar 

  • Chen L, Li H, Han L, Zhang K, Wang G, Wang Y, Liu Y, Zheng Y, Jiang T, Pu P, Jiang C, Kang C (2011b) Expression and function of miR-27b in human glioma. Oncol Rep 26:1617–21

    PubMed  CAS  Google Scholar 

  • Cselenyi CS, Jernigan KK, Tahinci E, Thorne CA, Lee LA, Lee E (2008) LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3’s phosphorylation of beta-catenin. Proc Natl Acad Sci U S A 105:8032–7

    Article  PubMed  CAS  Google Scholar 

  • Daniels DL, Weis WI (2005) Beta-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat Struct Mol Biol 12:364–71

    Article  PubMed  CAS  Google Scholar 

  • Dominguez I, Itoh K, Sokol SY (1995) Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proc Natl Acad Sci U S A 92:8498–502

    Article  PubMed  CAS  Google Scholar 

  • Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon RT, Teo JL, Kim HY, Moon SH, Ha JR, Kahn M (2004) A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. Proc Natl Acad Sci U S A 101:12682–7

    Article  PubMed  CAS  Google Scholar 

  • Estrach S, Ambler CA, Lo Celso C, Hozumi K, Watt FM (2006) Jagged 1 is a beta-catenin target gene required for ectopic hair follicle formation in adult epidermis. Development 133:4427–38

    Article  PubMed  CAS  Google Scholar 

  • Ettenberg SA, Charlat O, Daley MP, Liu S, Vincent KJ, Stuart DD, Schuller AG, Yuan J, Ospina B, Green J, Yu Q, Walsh R, Li S, Schmitz R, Heine H, Bilic S, Ostrom L, Mosher R, Hartlepp KF, Zhu Z, Fawell S, Yao YM, Stover D, Finan PM, Porter JA, Sellers WR, Klagge IM, Cong F (2010) Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies. Proc Natl Acad Sci U S A 107:15473–8

    Article  PubMed  CAS  Google Scholar 

  • Finkbeiner MG, Sawan C, Ouzounova M, Murr R, Herceg Z (2008) HAT cofactor TRRAP mediates beta-catenin ubiquitination on the chromatin and the regulation of the canonical Wnt pathway. Cell Cycle 7:3908–14

    Article  PubMed  CAS  Google Scholar 

  • Fuerer C, Habib SJ, Nusse R (2010) A study on the interactions between heparan sulfate proteoglycans and Wnt proteins. Dev Dyn 239:184–90

    PubMed  CAS  Google Scholar 

  • Garcia R, Yu CL, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP, Jove R (1997) Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ 8:1267–76

    PubMed  CAS  Google Scholar 

  • Grandy D, Shan J, Zhang X, Rao S, Akunuru S, Li H, Zhang Y, Alpatov I, Zhang XA, Lang RA, Shi DL, Zheng JJ (2009) Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled. J Biol Chem 284:16256–63

    Google Scholar 

  • Han L, Yang Y, Yue X, Huang K, Liu X, Pu P, Jiang H, Yan W, Jiang T, Kang C (2010) Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of beta-catenin-mediated transcription. Brain Res 1366:9–17

    Article  PubMed  CAS  Google Scholar 

  • Handeli S, Simon JA (2008) A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities. Mol Cancer Ther 7:521–9

    Article  PubMed  CAS  Google Scholar 

  • He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H (1997) A member of the Frizzled protein family mediating axis induction by Wnt-5A. Science 275:1652–4

    Article  PubMed  CAS  Google Scholar 

  • Ingham PW, Taylor AM, Nakano Y (1991) Role of the Drosophila patched gene in positional signalling. Nature 353:184–7

    Article  PubMed  CAS  Google Scholar 

  • Itasaki N, Jones CM, Mercurio S, Rowe A, Domingos PM, Smith JC, Krumlauf R (2003) Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 130:4295–305

    Article  PubMed  CAS  Google Scholar 

  • Ji H, Wang J, Fang B, Fang X, Lu Z (2011a) Alpha-Catenin inhibits glioma cell migration, invasion, and proliferation by suppression of beta-catenin transactivation. J Neurooncol 103:445–51

    Article  PubMed  CAS  Google Scholar 

  • Ji J, Yamashita T, Wang XW (2011b) Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma. Cell Biosci 1:4

    Article  PubMed  CAS  Google Scholar 

  • Jiang L, Wu J, Chen Q, Hu X, Li W, Hu G (2011) Notch1 expression is upregulated in glioma and is associated with tumor progression. J Clin Neurosci 18:387–90

    Article  PubMed  CAS  Google Scholar 

  • Jin X, Jeon HY, Joo KM, Kim JK, Jin J, Kim SH, Kang BG, Beck S, Lee SJ, Park AK, Park WY, Choi YJ, Nam DH, Kim H (2011) Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res 71:3066–75

    Article  PubMed  CAS  Google Scholar 

  • Kamino M, Kishida M, Kibe T, Ikoma K, Iijima M, Hirano H, Tokudome M, Chen L, Koriyama C, Yamada K, Arita K, Kishida S (2011) Wnt-5a signaling is correlated with infiltrative activity in human glioma by inducing cellular migration and MMP-2. Cancer Sci 102:540–8

    Article  PubMed  CAS  Google Scholar 

  • Kang CS, Pu PY, Li YH, Zhang ZY, Qiu MZ, Huang Q, Wang GX (2005) An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor. J Neurooncol 74:267–73

    Article  PubMed  CAS  Google Scholar 

  • Kang CS, Zhang ZY, Jia ZF, Wang GX, Qiu MZ, Zhou HX, Yu SZ, Chang J, Jiang H, Pu PY (2006) Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo. Cancer Gene Ther 13:530–8

    Article  PubMed  CAS  Google Scholar 

  • Kang SH, Yu MO, Park KJ, Chi SG, Park DH, Chung YG (2010) Activated STAT3 regulates hypoxia-induced angiogenesis and cell migration in human glioblastoma. Neurosurgery 67:1386–95, discussion 1395

    Article  PubMed  Google Scholar 

  • Kim SJ, Shin JY, Cheong TC, Choi IJ, Lee YS, Park SH, Chun KH (2011) Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of beta-catenin in gastric cancer. Clin Exp Metastasis

  • Kongkham PN, Northcott PA, Croul SE, Smith CA, Taylor MD, Rutka JT (2010) The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma. Oncogene 29:3017–24

    Article  PubMed  CAS  Google Scholar 

  • Krasnow RE, Wong LL, Adler PN (1995) Dishevelled is a component of the frizzled signaling pathway in Drosophila. Development 121:4095–102

    PubMed  CAS  Google Scholar 

  • Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodearl AD, Gearing DP, Sokol SY, McCarthy SA (1999) Functional and structural diversity of the human Dickkopf gene family. Gene 238:301–13

    Article  PubMed  CAS  Google Scholar 

  • Kulkarni NH, Onyia JE, Zeng Q, Tian X, Liu M, Halladay DL, Frolik CA, Engler T, Wei T, Kriauciunas A, Martin TJ, Sato M, Bryant HU, Ma YL (2006) Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. J Bone Miner Res 21:910–20

    Google Scholar 

  • Lan F, Yue X, Han L, Shi Z, Yang Y, Pu P, Yao Z, Kang C (2011a) Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role. Int J Oncol

  • Lan F, Yue X, Han L, Yuan X, Shi Z, Huang K, Yang Y, Zou J, Zhang J, Jiang T, Pu P, Kang C (2011b) Antitumor effect of aspirin in glioblastoma cells by modulation of beta-catenin/T-cell factor-mediated transcriptional activity. J Neurosurg 115:780–8

    Article  PubMed  CAS  Google Scholar 

  • Lee CH, Hung HW, Hung PH, Shieh YS (2010) Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer. Mol Cancer 9:64

    Article  PubMed  CAS  Google Scholar 

  • Lepourcelet M, Chen YN, France DS, Wang H, Crews P, Petersen F, Bruseo C, Wood AW, Shivdasani RA (2004) Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5:91–102

    Article  PubMed  CAS  Google Scholar 

  • Leushacke M, Barker N (2011) Lgr5 and Lgr6 as markers to study adult stem cell roles in self-renewal and cancer. Oncogene

  • Li J, Sutter C, Parker DS, Blauwkamp T, Fang M, Cadigan KM (2007) CBP/p300 are bimodal regulators of Wnt signaling. EMBO J 26:2284–94

    Article  PubMed  CAS  Google Scholar 

  • Li GH, Wei H, Lv SQ, Ji H, Wang DL (2010a) Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells. Int J Oncol 37:103–10

    PubMed  Google Scholar 

  • Li Y, Lu HM, Li G, Yan GM (2010b) Glycogen synthase kinase-3beta regulates astrocytic differentiation of U87-MG human glioblastoma cells. Acta Pharmacol Sin 31:355–60

    Article  PubMed  CAS  Google Scholar 

  • Li J, Cui Y, Gao G, Zhao Z, Zhang H, Wang X (2011) Notch1 is an independent prognostic factor for patients with glioma. J Surg Oncol 103:813–7

    Article  PubMed  CAS  Google Scholar 

  • Lin L, Liu A, Peng Z, Lin HJ, Li PK, Li C, Lin J (2011) STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res

  • Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X (2002) Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108:837–47

    Article  PubMed  CAS  Google Scholar 

  • Liu C, Tu Y, Sun X, Jiang J, Jin X, Bo X, Li Z, Bian A, Wang X, Liu D, Wang Z, Ding L (2011) Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations. Clin Exp Med 11:105–12

    Article  PubMed  CAS  Google Scholar 

  • Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810

    Article  PubMed  CAS  Google Scholar 

  • Lu J, Zhang F, Zhao D, Hong L, Min J, Zhang L, Li F, Yan Y, Li H, Ma Y, Li Q (2008) ATRA-inhibited proliferation in glioma cells is associated with subcellular redistribution of beta-catenin via up-regulation of Axin. J Neurooncol 87:271–7

    Article  PubMed  CAS  Google Scholar 

  • Lu W, Tinsley HN, Keeton A, Qu Z, Piazza GA, Li Y (2009) Suppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferation. Eur J Pharmacol 602:8–14

    Article  PubMed  CAS  Google Scholar 

  • Ma X, Lv Y, Liu J, Wang D, Huang Q, Wang X, Li G, Xu S, Li X (2009) Survival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in China. J Clin Neurosci 16:1595–8

    Article  PubMed  Google Scholar 

  • McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R, Alessi DR (2005) Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis. EMBO J 24:1571–83

    Article  PubMed  CAS  Google Scholar 

  • Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M, Hirano T (1996) A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15:3651–8

    PubMed  CAS  Google Scholar 

  • Nakamura T, Hamada F, Ishidate T, Anai K, Kawahara K, Toyoshima K, Akiyama T (1998) Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level. Genes Cells 3:395–403

    Article  PubMed  CAS  Google Scholar 

  • Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25:7469–81

    Article  PubMed  CAS  Google Scholar 

  • Palos TP, Zheng S, Howard BD (1999) Wnt signaling induces GLT-1 expression in rat C6 glioma cells. J Neurochem 73:1012–23

    Article  PubMed  CAS  Google Scholar 

  • Papkoff J, Rubinfeld B, Schryver B, Polakis P (1996) Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol Cell Biol 16:2128–34

    PubMed  CAS  Google Scholar 

  • Park S, Gwak J, Cho M, Song T, Won J, Kim DE, Shin JG, Oh S (2006) Hexachlorophene inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin degradation. Mol Pharmacol 70:960–6

    Article  PubMed  CAS  Google Scholar 

  • Pecina-Slaus N, Beros V, Houra K, Cupic H (2006) Loss of heterozygosity of the APC gene found in a single case of oligoastrocytoma. J Neurooncol 78:213–5

    Article  PubMed  CAS  Google Scholar 

  • Pecina-Slaus N, Martic TN, Kokotovic T, Kusec V, Tomas D, Hrascan R (2011) AXIN-1 protein expression and localization in glioblastoma. Coll Antropol 35(Suppl 1):101–6

    PubMed  CAS  Google Scholar 

  • Perrimon N, Mahowald AP (1987) Multiple functions of segment polarity genes in Drosophila. Dev Biol 119:587–600

    Article  PubMed  CAS  Google Scholar 

  • Pu P, Kang C, Li J, Jiang H, Cheng J (2006) The effects of antisense AKT2 RNA on the inhibition of malignant glioma cell growth in vitro and in vivo. J Neurooncol 76:1–11

    Article  PubMed  CAS  Google Scholar 

  • Pu P, Zhang Z, Kang C, Jiang R, Jia Z, Wang G, Jiang H (2009) Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther 16:351–61

    Article  PubMed  CAS  Google Scholar 

  • Pulvirenti T, Van Der Heijden M, Droms LA, Huse JT, Tabar V, Hall A (2011) Dishevelled 2 signaling promotes self-renewal and tumorigenicity in human gliomas. Cancer Res 71:7280–90

    Article  PubMed  CAS  Google Scholar 

  • Qiang YW, Endo Y, Rubin JS, Rudikoff S (2003) Wnt signaling in B-cell neoplasia. Oncogene 22:1536–45

    Article  PubMed  CAS  Google Scholar 

  • Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A, Anant S, Queimado L (2011) Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Oncogene

  • Rossi M, Magnoni L, Miracco C, Mori E, Tosi P, Pirtoli L, Tini P, Oliveri G, Cosci E, Bakker A (2011) beta-catenin and Gli1 are prognostic markers in glioblastoma. Cancer Biol Ther 11:753–61

    Article  PubMed  Google Scholar 

  • Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J, Weller M (2000) Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 19:4210–20

    Article  PubMed  CAS  Google Scholar 

  • Salomon D, Sacco PA, Roy SG, Simcha I, Johnson KR, Wheelock MJ, Ben-Ze’ev A (1997) Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. J Cell Biol 139:1325–35

    Article  PubMed  CAS  Google Scholar 

  • Sareddy GR, Panigrahi M, Challa S, Mahadevan A, Babu PP (2009) Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas. Neurochem Int 55:307–17

    Article  PubMed  CAS  Google Scholar 

  • Satoh J, Kuroda Y (2000) Beta-catenin expression in human neural cell lines following exposure to cytokines and growth factors. Neuropathology 20:113–23

    Article  PubMed  CAS  Google Scholar 

  • Saydam O, Shen Y, Wurdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM, Breakefield XO (2009) Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Mol Cell Biol 29:5923–40

    Article  PubMed  CAS  Google Scholar 

  • Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Orntoft TF, Andersen CL (2011) Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Oncogene

  • Sherry MM, Reeves A, Wu JK, Cochran BH (2009) STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells. Stem Cells 27:2383–92

    Article  PubMed  CAS  Google Scholar 

  • Shimizu T, Kagawa T, Inoue T, Nonaka A, Takada S, Aburatani H, Taga T (2008) Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells. Mol Cell Biol 28:7427–41

    Article  PubMed  CAS  Google Scholar 

  • Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 352:987–996

    Article  PubMed  CAS  Google Scholar 

  • Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff R-O (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466

    Article  PubMed  CAS  Google Scholar 

  • Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X (2000) LDL-receptor-related proteins in Wnt signal transduction. Nature 407:530–5

    Article  PubMed  CAS  Google Scholar 

  • Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z, He X (2004) A mechanism for Wnt coreceptor activation. Mol Cell 13:149–56

    Article  PubMed  CAS  Google Scholar 

  • Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S, Monga DK, Bell A, Michalopoulos GK, Monga SP (2005) Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology 129:285–302

    Article  PubMed  CAS  Google Scholar 

  • Thorne CA, Hanson AJ, Schneider J, Tahinci E, Orton D, Cselenyi CS, Jernigan KK, Meyers KC, Hang BI, Waterson AG, Kim K, Melancon B, Ghidu VP, Sulikowski GA, LaFleur B, Salic A, Lee LA, Miller DM, 3rd, Lee E (2010) Small-molecule inhibition of Wnt signaling through activation of casein kinase 1alpha. Nat Chem Biol 6:829–36

  • Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L, Quest AF (2007) E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription. Mol Cell Biol 27:7703–17

    Article  PubMed  CAS  Google Scholar 

  • Tseng AS, Engel FB, Keating MT (2006) The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol 13:957–63

    Google Scholar 

  • Uchino M, Kojima H, Wada K, Imada M, Onoda F, Satofuka H, Utsugi T, Murakami Y (2010) Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells. BMC Cancer 10:414

    Article  PubMed  CAS  Google Scholar 

  • Ungerback J, Elander N, Grunberg J, Sigvardsson M, Soderkvist P (2011) The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells. PLoS One 6:e17957

    Article  PubMed  CAS  Google Scholar 

  • Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottaro DP, Cumberledge S, Rubin JS (2000) Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem 275:4374–82

    Article  PubMed  CAS  Google Scholar 

  • Wang J, Wang C, Meng Q, Li S, Sun X, Bo Y, Yao W (2011a) siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth. Mol Biol Rep

  • Wang L, Cheng H, Liu Y, Yu W, Zhang G, Chen B, Yu Z, Hu S (2011b) Prognostic value of nuclear beta-catenin overexpression at invasive front in colorectal cancer for synchronous liver metastasis. Ann Surg Oncol 18:1553–9

    Article  PubMed  Google Scholar 

  • Wang XH, Meng XW, Xing H, Qu B, Han MZ, Chen J, Fan YJ, Lu CQ, Lu ZW (2011c) STAT3 and beta-catenin signaling pathway may affect GSK-3beta expression in hepatocellular carcinoma. Hepatogastroenterology 58:487–91

    Article  PubMed  CAS  Google Scholar 

  • Wang Y, Chen L, Bao Z, Li S, You G, Yan W, Shi Z, Liu Y, Yang P, Zhang W, Han L, Kang C, Jiang T (2011d) Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and beta-catenin signaling pathways. Oncol Rep 26:1173–80

    PubMed  Google Scholar 

  • Wodarz A, Nusse R (1998) Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59–88

    Article  PubMed  CAS  Google Scholar 

  • Wu CH, Nusse R (2002) Ligand receptor interactions in the Wnt signaling pathway in Drosophila. J Biol Chem 277:41762–9

    Article  PubMed  CAS  Google Scholar 

  • Xu P, Qiu M, Zhang Z, Kang C, Jiang R, Jia Z, Wang G, Jiang H, Pu P (2010) The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo. J Neurooncol 97:41–51

    Article  PubMed  CAS  Google Scholar 

  • Yan S, Zhou C, Zhang W, Zhang G, Zhao X, Yang S, Wang Y, Lu N, Zhu H, Xu N (2008) Beta-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma. Cancer Lett 271:85–97

    Article  PubMed  CAS  Google Scholar 

  • Yang Z, Wang Y, Fang J, Chen F, Liu J, Wu J, Song T, Zeng F, Rao Y (2010) Downregulation of WIF-1 by hypermethylation in astrocytomas. Acta Biochim Biophys Sin (Shanghai) 42:418–25

    Article  CAS  Google Scholar 

  • Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, Gao X, Aldape K, Lu Z (2011) Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 480:118–22

    Article  PubMed  CAS  Google Scholar 

  • Yu JM, Jun ES, Jung JS, Suh SY, Han JY, Kim JY, Kim KW (2007) Role of Wnt5a in the proliferation of human glioblastoma cells. Cancer Lett 257:172–81

    Article  PubMed  CAS  Google Scholar 

  • Yue X, Lan F, Yang W, Yang Y, Han L, Zhang A, Liu J, Zeng H, Jiang T, Pu P, Kang C (2010) Interruption of beta-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells. Brain Res 1366:27–37

    Article  PubMed  CAS  Google Scholar 

  • Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL 3rd, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F (1997) The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90:181–92

    Article  PubMed  CAS  Google Scholar 

  • Zhang Z, Schittenhelm J, Guo K, Buhring HJ, Trautmann K, Meyermann R, Schluesener HJ (2006) Upregulation of frizzled 9 in astrocytomas. Neuropathol Appl Neurobiol 32:615–24

    Article  PubMed  CAS  Google Scholar 

  • Zhang LY, Ye J, Zhang F, Li FF, Li H, Gu Y, Liu F, Chen GS, Li Q (2009) Axin induces cell death and reduces cell proliferation in astrocytoma by activating the p53 pathway. Int J Oncol 35:25–32

    Article  PubMed  CAS  Google Scholar 

  • Zhang J, Han L, Zhang A, Wang Y, Yue X, You Y, Pu P, Kang C (2010) AKT2 expression is associated with glioma malignant progression and required for cell survival and invasion. Oncol Rep 24:65–72

    PubMed  Google Scholar 

  • Zhang J, Huang K, Shi Z, Zou J, Wang Y, Jia Z, Zhang A, Han L, Yue X, Liu N, Jiang T, You Y, Pu P, Kang C (2011) High beta-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Neuro Oncol 13:600–9

    Article  PubMed  CAS  Google Scholar 

  • Zhang X, Chen T, Zhang J, Mao Q, Li S, Xiong W, Qiu Y, Xie Q, Ge J (2012) Notch1 promotes glioma cell migration and invasion by stimulating beta-catenin and NF-kappaB signaling via AKT activation. Cancer Sci 103:181–90

    Article  PubMed  CAS  Google Scholar 

  • Zhou J, Cheng P, Youn JI, Cotter MJ, Gabrilovich DI (2009) Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity 30:845–59

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the China National Natural Scientific Fund (30971136, 30872657), the Tianjin Science and Technology Committee (09JCZDJC17600), the Program for New Century Excellent Talents in University (NCET-07-0615) and the National High Technology Research and Development Program 863 (2012AA02A508).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chunsheng Kang.

Additional information

Kailiang Zhang and Junxia Zhang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, K., Zhang, J., Han, L. et al. Wnt/beta-Catenin Signaling in Glioma. J Neuroimmune Pharmacol 7, 740–749 (2012). https://doi.org/10.1007/s11481-012-9359-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-012-9359-y

Keywords

Navigation